CIBC Asset Management’s Guardant Health GH Stock Holding History

CIBC Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$609K	Sell	4,056 -463	-10%	-$50.4K	﹤0.01%	796
2026 Q1	$417K	Hold	4,519	–	–	﹤0.01%	846
2025 Q4	$462K	Buy	4,519 +583	+15%	+$52.2K	﹤0.01%	824
2025 Q3	$246K	Hold	3,936	–	–	﹤0.01%	1042
2025 Q2	$205K	Buy	+3,936	New	+$176K	﹤0.01%	1114
2022 Q4	–	Sell	-3,959	Closed	-$213K	–	1139
2022 Q3	$213K	Buy	+3,959	New	+$203K	﹤0.01%	1057
2022 Q2	–	Sell	-4,248	Closed	-$281K	–	1356
2022 Q1	$281K	Hold	4,248	–	–	﹤0.01%	1106
2021 Q4	$425K	Buy	4,248 +160	+4%	+$16.5K	﹤0.01%	894
2021 Q3	$511K	Buy	4,088 +391	+11%	+$46.5K	﹤0.01%	819
2021 Q2	$459K	Hold	3,697	–	–	﹤0.01%	831
2021 Q1	$564K	Buy	3,697 +214	+6%	+$32.3K	﹤0.01%	770
2020 Q4	$449K	Hold	3,483	–	–	﹤0.01%	770
2020 Q3	$389K	Buy	3,483 +86	+3%	+$7.87K	﹤0.01%	756
2020 Q2	$276K	Hold	3,397	–	–	﹤0.01%	826
2020 Q1	$236K	Hold	3,397	–	–	﹤0.01%	814
2019 Q4	$265K	Buy	+3,397	New	+$245K	﹤0.01%	925

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

CIBC Asset Management's GH Position: Q2 2026 in Review

CIBC Asset Management reduced its Guardant Health (GH) stake by 10% in Q2 2026, selling an estimated $50.4K and leaving 4,056 shares worth $609K. The position accounts for ﹤0.01% of the portfolio, ranked #796.

CIBC Asset Management first reported a position in GH in Q4 2019 and has held it in 16 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

CIBC Asset Management held 4,056 shares of Guardant Health worth $609K as of Q2 2026.
CIBC Asset Management sold 463 Guardant Health shares in Q2 2026, an estimated $50.4K.
Guardant Health made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #796 holding.
CIBC Asset Management first reported a position in Guardant Health in Q4 2019 and has held it in 16 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.